Services
Genomic Testing
Companion Diagnostic Test
Laboratory Developed Tests (LDT)
Solid Tumors
Hematologic Malignancies
Hereditary Cancers
Minimal Residual Disease
Research Services
Platforms
DNA Sequencing
RNA Sequencing
Other Services
Technology
Our Technology
Publications
Partnerships
About Us
What is Precision Oncology?
Our Company
Our Team
Certificates & Accreditation
News
Join Us
Contact Us
Ch|中文
Search
May 25, 2023
GENESEEQ TO SHOWCASE NEW FINDINGS AT ASCO 2023
by Geneseeq
March 9, 2023
Geneseeq and Collaborators Initiate MOTION Study to Evaluate the Performance of Minimal Residual Disease Test SHIELDING™ in Early-stage Lung Cancer
by Geneseeq
January 24, 2023
Geneseeq receives CE Marks for MRD and MCED tests.
by Geneseeq
May 31, 2022
Geneseeq at ASCO 2022
by Geneseeq
April 27, 2021
Geneseeq and AstraZeneca Collaborate to Build Guangzhou Bio-Diagnostics Innovation Center
by Geneseeq
Privacy Preference Center
Privacy Preferences